Breaking News
September 25, 2018 - New therapeutic vaccine helps immune cells fight HPV-related head and neck cancer
September 25, 2018 - Environmentally-induced gene activity influences IQ test performance
September 25, 2018 - Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI
September 25, 2018 - FDA Approves Copiktra (duvelisib) Capsules for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma
September 25, 2018 - Medical device company settles US case over false claims
September 25, 2018 - Trying to get answers: One woman’s quest for a diagnosis
September 25, 2018 - Lung cancer patients treated with invasive surgery more likely to become chronic opioid users
September 25, 2018 - Oxford VR raises £3.2m to boost innovation in VR for mental health problems
September 25, 2018 - Gene therapy approach could help treat mitochondrial diseases
September 25, 2018 - Few Yogurt Products Qualify As Low-Sugar
September 25, 2018 - Eye disease can cause blindness, and it’s on the rise
September 25, 2018 - Pawnshop density linked to gun-related suicides, Stanford study finds
September 25, 2018 - Pioneering procedure for common prostate condition offered by The London Clinic
September 25, 2018 - Number of people with respiratory diseases likely to increase if UK air pollution remains unchecked
September 25, 2018 - FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial
September 25, 2018 - New program to reduce harmful stress effectively improves mood in cancer patients
September 24, 2018 - Florence’s Lingering Threat: Mold – Drugs.com MedNews
September 24, 2018 - For professional baseball players, faster hand-eye coordination linked to batting performance
September 24, 2018 - Bill for later school start times is defeated, but Stanford sleep specialist isn’t
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Successful recovery from addiction means more than achieving abstinence
September 24, 2018 - New nanoplatform technology may reverse drug-resistance in renal cell carcinoma
September 24, 2018 - October 1918 marks the centenary of Spanish Flu that claimed more lives than World War I
September 24, 2018 - LGBT community reports more number of poor mental health days than general population
September 24, 2018 - New research suggests power of zebrafish as tool for cancer drug discovery
September 24, 2018 - New study finds height as possible risk factor for developing varicose veins
September 24, 2018 - Researchers compare weight loss results of online and in-person diabetes prevention program
September 24, 2018 - New HER2 PET Study Uses Affibody’s ABY-025 Tracer to Individualize Breast Cancer Treatment
September 24, 2018 - Drug combination offers more effective care for patients suffering miscarriage
September 24, 2018 - Tallness linked to varicose veins, Stanford study says
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Ecstasy drug makes octopuses more social
September 24, 2018 - Immediate compression therapy could cut risk of complications after deep-vein thrombosis
September 24, 2018 - Transcatheter mitral valve repair reduces mortality for patients with mitral regurgitation
September 24, 2018 - First intracranial aneurysm patients treated with BRAVO Flow Diverter after CE mark approval
September 24, 2018 - ‘Physicians of the mouth’? Dentists absorb the medical billing drill
September 24, 2018 - People more likely to believe those with confident tone of voice than with accent
September 24, 2018 - Harmony Biosciences Presents 5-Year Data On Pitolisant At International Narcolepsy Symposium
September 24, 2018 - Blood test may identify gestational diabetes risk in first trimester
September 24, 2018 - Height may be risk factor for varicose veins | News Center
September 24, 2018 - King’s commemorates opening of new NMR facility with one-day symposium
September 24, 2018 - Eisai receives approval for partial label change of DC Bead device for transcatheter arterial embolization
September 24, 2018 - Using multi-level approach to reduce underage drinking among youths on rural reservations
September 24, 2018 - High-resolution genomic map gives scientists unprecedented view of brain development
September 24, 2018 - Researchers find impact of neurobehavioral symptoms on employment in adults with TBI
September 24, 2018 - Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD
September 24, 2018 - First evaluation of benefits, harms of Alzheimer’s screening for family members of older adults
September 24, 2018 - Ancora Heart announces positive data of study evaluating AccuCinch Ventricular Repair System
September 24, 2018 - Children of mothers using cannabis may start using it at an earlier age, finds study
September 24, 2018 - Gilead Sciences plans to launch authorized generic versions of Epclusa and Harvoni in the US
September 24, 2018 - Most patients who underwent transcatheter valve replacement experience prosthesis-patient mismatch
September 24, 2018 - Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone
September 24, 2018 - New study provides basis for Air Canada to change its facial hair policy for aircrew
September 24, 2018 - Infant walkers lead to thousands of emergency visits for babies
September 24, 2018 - Genes predicting person’s height may provide clues about causes of varicose veins
September 24, 2018 - EPA Plan Will Maintain Carbon Emissions From Power Plants
September 24, 2018 - Characterizing pig hippocampus could improve translational neuroscience
September 24, 2018 - Element3 Health reports social and mental engagement play key role in overall health
September 24, 2018 - Paralympic medalists support Fight for Sight’s unique virtual event
September 24, 2018 - ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma
September 24, 2018 - Public awareness of urological conditions found to be alarmingly low across Europe
September 24, 2018 - Fitter Folks Suffer Milder Strokes: Study
September 24, 2018 - Novel botulinum toxin compound relieves chronic pain
September 24, 2018 - CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents
September 24, 2018 - National Friendly’s private medical insurance is a hit with women living in the South East
September 24, 2018 - Academics receive prestigious awards for achievements in blood pressure research
September 24, 2018 - Obese pregnant women can restrict weight gain safely with proper nutrition guidance
September 24, 2018 - CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer
September 24, 2018 - China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma
September 24, 2018 - A new approach for finding Alzheimer’s treatments
September 24, 2018 - USC research uncovers previously unknown genetic risk factor for dementia
September 24, 2018 - Study examining mental health among students finds significant disparities in treatment across race
September 24, 2018 - Breakthrough discovery paves way for future test to identify drowsy drivers
September 24, 2018 - Transcatheter mitral-valve repair in patients with heart failure
September 24, 2018 - Study opens new avenues for treatment of Laing distal myopathy
September 24, 2018 - Stroke Facts | cdc.gov
September 24, 2018 - Sarcolipin tricks muscle cells into using more energy, burning fat
September 24, 2018 - Enrollment in opioid controlled substance agreement reduces primary care visits
September 24, 2018 - UTA researchers patent new smart seat cushion technology that helps prevent painful ulcers
September 24, 2018 - Second HPV-Related Primary Cancers Common in Survivors

Trump Declares Opioid Epidemic a Public Health Emergency

image_pdfDownload PDFimage_print

THURSDAY, Oct. 26, 2017 — In his first major speech Thursday on the opioid epidemic in the United States, President Donald Trump declared the crisis a public health emergency.

“As Americans, we cannot allow this to continue,” Trump said in a speech from the White House. “It is time to liberate our communities from the scourge. We can be the generation that ends the opioid epidemic.”

The president, flanked by First Lady Melania Trump and New Jersey Republican Gov. Chris Christie, added that fighting the problem “will require all of our effort, and it will require us to confront the crisis in all of its real complexity.”

Christie heads a special presidential commission on controlling the epidemic of opioid addiction.

The president held back from pushing the declaration from a “public” to a “national” state of emergency. A national state of emergency allows states access to money from the federal Disaster Relief Fund, as happens when hurricanes or other natural disasters are declared.

According to the Washington Post, White House officials told reporters that designating the opioid crisis a national state of emergency wasn’t appropriate for a longer-term issue and would add little to what can already be done under “public” emergency status.

The emergency status lasts for 90 days but can be renewed repeatedly.

According to the Post, the presidential memorandum that Trump signed Thursday mandates that acting Secretary of Health and Human Services Secretary Eric Hargan direct federal agencies to use their emergency authorities to bring down the number of opioid overdose deaths.

Similar actions have been taken before, the last being in 2009 in response to the H1N1 flu virus.

As the White House explained, under the new measures, new initiatives can be quickly rolled out. For example, people living in remote areas will get easier access to opioid-addiction treatment, and without the need to see a physician in person. States can quickly shift monies from federal grants over to efforts to fight the crisis. And the Department of Health and Human Services will accelerate hiring of personnel who might need to be deployed to various states.

But one major question remains: Where to find the federal funds to cover all these efforts.

As the Post noted, the Public Health Emergency Fund currently has only $57,000 in its coffers. The White House said it is working with Congress to find additional funds, which could run into the tens of billions of dollars. The White House did not issue any cost figures, however.

Cynthia Reilly, who directs the Substance Use Prevention and Treatment Initiative at the Pew Charitable Trusts, applauded the new move.

“We are pleased to see the Administration take a step to increase awareness about this public health crisis,” Reilly said. “Only 1 in 10 Americans with a substance use disorder get any kind of treatment, so expanding access to evidence-based therapies is key. Additional funding and other resources are needed to achieve this goal.”

During his campaign for the White House, Trump promised to make fighting addiction a top priority.

But getting the money for effective interventions has been an issue. At a congressional hearing Wednesday, Democrats and Republicans expressed frustration as they grilled Trump administration officials about shortfalls in federal spending to combat the opioid crisis, the Associated Press reported.

“I don’t understand why more resources aren’t flowing to help out a rural state like West Virginia,” said West Virginia Republican Rep. David McKinley.

Added Rep. Ben Ray Lujan, a New Mexico Democrat: “People at home don’t feel like they’re getting help.”

It’s been nearly a year since Congress and President Barack Obama approved $1 billion to deal with the opioid crisis. That money is gradually reaching places in need, but there have been setbacks and delays along the way, the AP reported.

“It is a great opportunity, but it comes with a lot of angst,” Tom Hill of the nonprofit National Council for Behavioral Health, an addiction treatment provider advocacy group, told the AP.

And in a statement, the American Medical Association said the nation’s opioid addiction epidemic remains a tough, moving target.

“The number of prescription opioids in the country is declining while the numbers of people dying from heroin and illicit fentanyl are increasing at a staggering rate,” the AMA said. “As it stands, it’s easier for patients to access heroin than to access evidence-based treatment and non-opioid pain care. There is plenty of work ahead, and the emergency declaration adds further urgency to this epidemic.”

More information

The U.S. National Institute on Drug Abuse has more on opioids.

©2017 HealthDay.

All rights reserved.

Posted: October 2017

Recommended for you

Tagged with:

About author

Related Articles